GC

Geoffrey Cumming

AnteoTech Limited | Non-Executive Director
Dr Cumming has over 20 years of experience in the healthcare and biotechnology market. His roles have progressed from pure research to sales and marketing roles through to Managing Director level and on the Board. Previously Managing Director of Roche Diagnostic Systems - Oceania Regional Centre. He was also Managing Director and CEO of Biosceptre Ltd, an Australian based biotechnology company commercializing a range of products in cancer diagnosis and treatment. During his tenure he was responsible for doing research from Sydney University through to product registration. This involved capital raising, managing Intellectual Property, investor relations and forging links with relevant international partners. He is the Chair of the Risk Committee.

Company and Role

Company
Title
Tenure
Since
ADO
AnteoTech Limited
  • Non-Executive Director
17yrs, 3mthApr 2009

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
ADO
AnteoTech Limited
02/06/26500,00024,267,7506,968,750N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
ADO
AnteoTech Limited
02/06/26
Sell
3,000,000$0.036$108,000On-market trade
ADO
AnteoTech Limited
26/11/25
Expiry
3,500,000$0.019$66,500Options expired
ADO
AnteoTech Limited
26/11/25
Issued
5,000,000$0.019$95,000Issue of options
ADO
AnteoTech Limited
16/12/24
Issued
1,000,000$0.020$20,000Rights issue
ADO
AnteoTech Limited
31/05/24
Issued
600,000$0.024$14,400Participation in share purchase plan